candidate selection

Candidate selection is the moment a project commits to one molecule and puts the others aside. After lead optimization has produced a handful of strong compounds, the team must pick the single best-balanced one to carry into the expensive, slow world of formal development. It is the discovery equivalent of choosing which athlete to send to the Olympics.

The choice is rarely about the most potent molecule. Teams weigh the whole package against the predefined candidate profile: potency and selectivity, ADMET behavior, safety signals, predicted human dose, ease of manufacture, and patentability. A compound that is merely good across all of these usually beats one that is spectacular in one area but weak in another, because development punishes hidden weaknesses harshly.

Because what comes next costs years and large sums, projects often advance a primary candidate plus one backup with a different liability profile, hedging against late failure. Even careful selection is a bet under uncertainty: many candidates still fail in animals or humans for reasons no early assay revealed.